2231
|
|
|
Cyclin dependent kinase inhibitor 1C |
BWCR, BWS, KIP2, WBS, p57, p57Kip2 |
Endometrial hyperplasia, Beckwith-wiedemann syndrome, Desbuquois syndrome, Endometrial neoplasms, Hyperinsulinism, Maturity-onset diabetes of the young (mody), Lung neoplasms, Melanoma, Rhabdomyosarcoma, Russell-silver syndrome, Schizophrenia, Silver-russell syndrome, Diabetes mellitus type 1, Diabetes mellitus type 2 |
2232
|
|
|
Cyclin dependent kinase inhibitor 2A |
ARF, CAI2, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16 |
Endometrial hyperplasia, B-cell acute lymphoblastic leukemia, B-lymphoblastic leukemia/lymphoma, Bone disease, Brain neoplasms, Brain stem neoplasms, Breast cancer, Breast neoplasms, Cancer, Carcinogenesis, Hepatocellular carcinoma, Non-small-cell lung carcinoma, Pancreatic ductal carcinoma, Squamous cell carcinoma, Cardiovascular disease, Obstructive airway disease, Colorectal cancer, Colorectal neoplasms, Coronary artery disease, Melanoma, Major depressive disorder, Esophageal neoplasms, Esophageal squamous cell carcinoma, Estrogen-receptor negative breast cancer, Atypical multiple mole melanoma syndrome, Pancreatic cancer, Glaucoma, Glioma, Hemorrhagic disease, Li-fraumeni syndrome, Liver neoplasms, Lung cancer, Lung neoplasms, Lymphatic metastasis, Lymphoma, Diffuse large b-cell lymphoma, Maffucci syndrome, Mesothelioma, Mouth neoplasms, Multiple myeloma, Nasopharyngeal carcinoma, Nasopharyngeal neoplasms, Neuroblastoma, Non-neoplastic peripheral nervous system disease, Ovarian cancer, Ovarian serous carcinoma, Pancreatic neoplasms, Peripheral nervous system disease, Peripheral neuropathy, Prostate cancer, Chronic obstructive pulmonary disease, Sezary syndrome, Stomach neoplasms, Thrombocytopenia, Trisomy, Diabetes mellitus type 2, Depression, Urinary bladder neoplasms, Urogenital neoplasms, Vulvar lichen sclerosusView all (45 more) |
2233
|
|
|
CDKN2A interacting protein |
- |
|
2234
|
|
|
CDKN2A interacting protein N-terminal like |
C2AIL |
|
2235
|
|
|
Cyclin dependent kinase inhibitor 2B |
CDK4I, INK4B, MTS2, P15, TP15, p15INK4b |
Alzheimer disease, Breast cancer, Hepatocellular carcinoma, Lymphoblastic leukemia, Ischemic heart disease, Coronary artery disease, Melanoma, Dementia, Glaucoma, Glioma, Liver neoplasms, Lung cancer, Lymphoma, Myelodysplastic syndrome, Myocardial ischemia, Nasopharyngeal neoplasms, Open angle glaucoma, Prostate cancer, Schizophrenia, Three-vessel coronary artery disease, Diabetes mellitus type 2View all (6 more) |
2236
|
|
|
Cyclin dependent kinase inhibitor 2C |
INK4C, p18, p18-INK4C |
Androgenetic alopecia, Anorexia nervosa, Attention deficit hyperactivity disorder, Breast cancer, Hepatocellular carcinoma, Cataract, Diabetes mellitus, Kidney cancer, Large artery stroke, Migraine, Prostate cancer, Schizophrenia, Diabetes mellitus type 2, Uterine fibroid |
2237
|
|
|
Cyclin dependent kinase inhibitor 2D |
INK4D, p19, p19-INK4D |
|
2238
|
|
|
Cyclin dependent kinase inhibitor 3 |
CDI1, CIP2, KAP, KAP1 |
|
2239
|
|
|
Cysteine dioxygenase type 1 |
CDO-I |
|
2240
|
|
|
Cell adhesion associated, oncogene regulated |
CDO, CDON1, HPE11, Ihog, ORCAM |
Alzheimer disease, Androgenetic alopecia, Kidney disease, Congenital ocular coloboma, Gastrointestinal stromal tumor, Holoprosencephaly, Microform holoprosencephaly, Syntelencephaly, Pituitary stalk interruption syndrome, Semilobar holoprosencephaly, Septopreoptic holoprosencephaly |
